Proof of Human, Promise of Profit

September 26, 2025

DENVER, Colo., Sep 26, 2025 (247marketnews.com)- In a move blending healthcare and privacy tech, Medirom Healthcare Technologies (NASDAQ:MRM) surged into the spotlight after announcing it will double the rollout of the Orb, a biometric authentication device developed by Worldcoin’s “World ID” initiative. The Orb purportedly verifies “humanness” allegedly without storing personal data, and is co-founded by Sam Altman and Alex Blania.

Datavault AI (NASDAQ:DVLT) grabbed headlines with one of the largest AI-bio crossovers of the year, a $150 million strategic investment from Scilex (NASDAQ:SCLX), executed in Bitcoin (BTC). The deal will fuel Datavault AI’s supercomputing infrastructure and the development of independent data exchanges targeting the $36 billion biotech data monetization market.

Scilex CEO Henry Ji, Ph.D., called it a “real global impact” opportunity, while DVLT CEO Nathaniel Bradley emphasized the strategic alignment with Brookhaven National Lab and IBM WatsonX.

The multi-phase deal also includes board seats for Scilex and limits future share issuances, signaling long-term alignment.

TEN Holdings (NASDAQ:XHLD) is actively setting the stage, confirming appearances at three major investor conferences, including LD Micro Main Event in San Diego. The company said these are “critical opportunities” to align investor interest. Watch this one for potential acquisitions or product rollouts.

Fractyl Health (NASDAQ:GUTS) soared into the biotech limelight this morning, releasing statistically significant data from its REMAIN-1 study. In the pivotal 3-month readout, patients receiving the company’s Revita treatment continued to lose weight after stopping GLP-1 drugs like tirzepatide, while placebo patients regained weight, a crucial breakthrough.

Revita patients lost 2.5% more weight, while sham-treated patients gained back 10% (p=0.014).

The data not only validated the trial design but opens a new therapeutic category in post-GLP-1 weight maintenance, addressing what Dartmouth’s Dr. Shelby Sullivan calls “the largest gap in obesity care.” The company also announced a $60 million underwritten offering, priced at $1.00/share, to support the pivotal program through 2026.

Chijet Motor Company (NASDAQ:CJET) announced a private placement offering of up to $20 million. Priced at $0.15 per share with warrants at $0.18, the raise is designed to fuel operations for the EV manufacturer. With global EV funding tightening, this raise reflects confidence among institutional investors in CJET’s production and development roadmap.

PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 247 is a third-party media provider and has been compensated by paid by Microcap Advisory for providing ongoing XHLD market outreach and other services. Please review 247’s Full Disclaimer https://www.247marketnews.com/disclaimer/ or go to https://247marketnews.com/ten-holdings-event-solutions/ for additional 247marketnews.com XHLD disclosure. 247 has been paid by Microcap Advisory for providing ongoing XHLD market outreach and other services. This press release may include technical analysis for instructional purposes only and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (XHLD, MRM, DVLT, SCLX, GUTS, CJET)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.